Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2025-12-25 @ 8:15 PM
NCT ID: NCT02534935
Term: Skin candida
Organ System: Infections and infestations
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: None
Notes: MedDRA v20.0 for Group 1: 60mcg bivalent rLP2086 (\>=12 months to \<24 months), Group 2: 120mcg bivalent rLP2086 (\>=12 months to \<24 months), Group 3: HAV/Saline (\>=12 months to \<24 months); MedDRA v23.0 for booster stage and safety follow up groups.
Study: NCT02534935
Study Brief: Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 1 44 View
EG001 None 0 220 View
EG002 None 0 132 View
EG003 None 0 147 View
EG004 None 0 44 View
EG005 None 0 220 View
EG006 None 0 132 View